Barnes-Jewish Hospital
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1914-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.barnesjewish.org/
Clinical Trials
7
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Obstructive Sleep Apnea Treatment and Insulin Sensitivity in Pregnancy
- Conditions
- Insulin SensitivityObstructive Sleep ApneaPregnancy Related
- First Posted Date
- 2019-07-09
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Barnes-Jewish Hospital
- Registration Number
- NCT04013399
- Locations
- 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States
High-Flow Oxygen Therapy Following Tracheostomy
- Conditions
- Acute Respiratory Failure
- First Posted Date
- 2018-10-26
- Last Posted Date
- 2021-07-20
- Lead Sponsor
- Barnes-Jewish Hospital
- Target Recruit Count
- 61
- Registration Number
- NCT03721419
- Locations
- 🇺🇸
Barnes-Jewish Hospital, Saint Louis, Missouri, United States
Endotracheal Tube Cuff Pressures in Ventilated Patients
- Conditions
- Pneumonia, Ventilator-Associated
- First Posted Date
- 2016-11-01
- Last Posted Date
- 2018-01-18
- Lead Sponsor
- Barnes-Jewish Hospital
- Target Recruit Count
- 305
- Registration Number
- NCT02950519
- Locations
- 🇺🇸
Barnes-Jewish Hospital, Saint Louis, Missouri, United States
Common Canister Protocol for Inhaler Administration in Mechanically Ventilated Patients
- Conditions
- Ventilator Associated Pneumonia
- First Posted Date
- 2013-09-05
- Last Posted Date
- 2016-10-07
- Lead Sponsor
- Barnes-Jewish Hospital
- Target Recruit Count
- 354
- Registration Number
- NCT01935388
- Locations
- 🇺🇸
Barnes-Jewish Hospital, Saint Louis, Missouri, United States
MIOX for Early Detection of Acute Kidney Injury After Cardiac Surgery
- Conditions
- Acute Kidney Injury
- First Posted Date
- 2013-08-07
- Last Posted Date
- 2013-08-07
- Lead Sponsor
- Barnes-Jewish Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT01918046
- Locations
- 🇺🇸
Barnes-Jewish Hospital, St.Louis, Missouri, United States
- Prev
- 1
- 2
- Next
News
Universal CAR-T Cell Therapy Achieves 91% Response Rate in Aggressive T Cell Cancers
An international Phase I/II trial of WU-CART-007, a universal CAR-T cell therapy, demonstrated a 91% overall response rate in patients with relapsed or refractory T cell acute lymphoblastic leukemia and T cell lymphoblastic lymphoma.
Nusayba Bagegni Receives NCI Early Career Award for Breast Cancer Research
Dr. Nusayba Bagegni, a medical oncologist at Washington University, has received the 2024 Early Career Cancer Clinical Investigator Award from the NCI.
MOST Trial: Anti-Clotting Drugs Fail to Improve Outcomes in Stroke Patients
The MOST trial investigated the efficacy of adding argatroban or eptifibatide to intravenous thrombolysis for stroke patients to prevent further clots.